Recently, an arginine-to-cysteine homozygous mutation at position 25 in mature parathyroid hormone was reported in a Korean patient with hypoparathyroidism. To clarify whether the high bone mass phenotype observed in this patient was related to the hypoparathyroidism itself or to chronic elevation of mutant PTH.